• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Wednesday, February 1, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

This Rakesh Jhunjhunwala stock is up 92% since March; there may still be more upside

by The Outlooker Web Desk
December 8, 2020
in Business
0
Nifty nears 13,050, share markets continue to log record highs; should you invest or wait?
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

In the international business, except for Metribuzin, RALI’s capacities are fully booked for the next quarter, indicating sustained momentum.

Rallis India’s share price has almost doubled since the end of March this year, having gained 92%. Rallis India stock has jumped from its March lows of Rs 149 apiece to Rs 286 per share now. However, that may not be the end to this Tata Group firm that operates in the farming sector, as analysts see Rallis India’s gaining market share in both domestic and international markets helped by the firm’s aggressive pricing strategy. Ace investor Rakesh Jhunjhunwala is also a known investor in Rallis India, holding over 10% stake in the firm.

In the recent analyst meet, Rallis India’s management said that the company aims to enter the top-3 club of the largest players in the agrochemical space. “Management expects that due to agri reforms, improving irrigation and government support on manufacturing should help the agrochemical industry to grow at 8-10% CAGR over the next 4-5 years vs. 5-6% CAGR over the last 5 years,” brokerage and research firm Emkay Global said in a recent report. Although scaling higher to reach 18% EBITDA margins by financial year 2023 is a tough task, Rallis India is looking to sustain or improve working capital efficiency to aid growth.

In the international business, except for Metribuzin, RALI’s capacities are fully booked for the next quarter, indicating sustained momentum, according to Emkay Global. Rallis India works in the areas of crop protection, contract manufacturing, seeds, and even has a strong international presence.

“We expect RALI to deliver 14% EPS CAGR over FY21-23E. We expect RALI’s ROE to improve 189bps over FY20-23E,” Emkay Global said. The brokerage firm said that ramp-up in Metribuzin capacity remains the key monitorable for the second half of this fiscal year. “We maintain Buy with a revised TP of Rs320, based 23x Dec’22E EPS,” they added. Rallis India has 4 ‘Strong Buy’ calls and 7 ‘Buy’ calls from analysts, according to Refinitiv.

The Big Bull Rakesh Jhunjhunwala has increased his stake in the firm from holding 1,93,05,820 equity shares at the end of the March quarter of the previous fiscal year to now holding 2,00,30,820 equity shares of Rallis India at the end of the September quarter of this fiscal year. In the month of November alone, the Big Bull made Rs 56 crore from Rallis India as the stock gained 11% during the previous month.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Mobiles Will Help India Launch World’s Largest Covid Vaccine Drive

Mobiles Will Help India Launch World's Largest Covid Vaccine Drive

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Drugs Worth Rs 2.68 Crore Seized In Manipur
National

Drugs Worth Rs 2.68 Crore Seized In Manipur

February 1, 2023
UP Woman Beats Man In Park Over Dispute, Investigation Underway: Cops
National

Maharashtra Woman Beaten, Paraded With Garland Of Shoes For Questioning Husband’s Death

January 31, 2023
Padma Awardee Author Sudha Murty’s 4-Point Advice To Son-In-Law Rishi Sunak
National

Padma Awardee Author Sudha Murty’s 4-Point Advice To Son-In-Law Rishi Sunak

January 31, 2023
Nitish Kumar’s Sulking Aide Upendra Kushwaha Recalls A 1994 Challenge To Lalu Yadav
National

Nitish Kumar’s Sulking Aide Upendra Kushwaha Recalls A 1994 Challenge To Lalu Yadav

January 31, 2023

Connect with us

No Result
View All Result

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Drugs Worth Rs 2.68 Crore Seized In Manipur
  • Maharashtra Woman Beaten, Paraded With Garland Of Shoes For Questioning Husband’s Death
  • Padma Awardee Author Sudha Murty’s 4-Point Advice To Son-In-Law Rishi Sunak

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.